Authors:
Gaillard, PJ
van der Meide, PH
de Boer, AG
Breimer, DD
Citation: Pj. Gaillard et al., Glucocorticoid and type I interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis, NEUROREPORT, 12(10), 2001, pp. 2189-2193
Authors:
Zhang, GX
Xiao, BG
Yu, LY
van der Meide, PH
Link, H
Citation: Gx. Zhang et al., Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR, J NEUROIMM, 113(1), 2001, pp. 10-18
Authors:
Wang, HB
Shi, FD
Li, HL
van der Meide, PH
Ljunggren, HG
Link, H
Citation: Hb. Wang et al., Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis, CLIN IMMUNO, 95(2), 2000, pp. 156-162
Authors:
Xu, LY
Ishikawa, M
Huang, YM
Levi, M
van der Meide, PH
Wahren, B
Link, H
Xiao, BG
Citation: Ly. Xu et al., The complexity of cytokine treatment in ongoing EAE induced with MBP peptide 68-86 in Lewis rats, CLIN IMMUNO, 95(1), 2000, pp. 70-78
Authors:
Hammarberg, H
Lidman, O
Lundberg, C
Eltayeb, SY
Gielen, AW
Muhallab, S
Svenningsson, A
Linda, H
van der Meide, PH
Cullheim, S
Olsson, T
Piehl, F
Citation: H. Hammarberg et al., Neuroprotection by encephalomyelitis: Rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells, J NEUROSC, 20(14), 2000, pp. 5283-5291
Authors:
Xu, LY
Yang, JS
Huang, YM
van der Meide, PH
Levi, M
Wahren, B
Link, H
Xiao, BG
Citation: Ly. Xu et al., Limitation of nitric oxide production: cells from lymph node and spleen exhibit distinct difference in nitric oxide production, IMMUNOL LET, 71(3), 2000, pp. 177-184
Authors:
Zou, LP
Ma, DH
Wei, L
van der Meide, PH
Mix, E
Zhu, J
Citation: Lp. Zou et al., IFN-beta suppresses experimental autoimmune neuritis in Lewis rats by inhibiting the migration of inflammatory cells into peripheral nervous tissue, J NEUROSC R, 56(2), 1999, pp. 123-130
Authors:
Zou, LP
Ma, DH
Levi, M
Wahren, B
Wei, L
Mix, E
van der Meide, PH
Link, H
Zhu, J
Citation: Lp. Zou et al., Antigen-specific immunosuppression: nasal tolerance to P0 protein peptidesfor the prevention and treatment of experimental autoimmune neuritis in Lewis rats, J NEUROIMM, 94(1-2), 1999, pp. 109-121
Authors:
Zhang, GX
Xiao, BG
Bai, XF
van der Meide, PH
Orn, A
Link, H
Citation: Gx. Zhang et al., Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis, J IMMUNOL, 162(7), 1999, pp. 3775-3781
Authors:
Shi, FD
Li, HL
Wang, HB
Bai, XF
van der Meide, PH
Link, H
Ljunggren, HG
Citation: Fd. Shi et al., Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: Identification of regulatory cells, J IMMUNOL, 162(10), 1999, pp. 5757-5763
Authors:
Bernard, I
Foucras, C
Cautain, B
van der Meide, PH
Druet, P
Guery, JC
Saoudi, A
Citation: I. Bernard et al., Flow cytometric analysis of intracellular interferon-gamma synthesis in rat CD4 T cells, EUR CYTOKIN, 9(4), 1998, pp. 613-618
Authors:
Coscarella, A
Liddi, R
Di Loreto, M
Bach, S
Faiella, A
van der Meide, PH
Mele, A
De Santis, R
Citation: A. Coscarella et al., The rhGM-CSF-EPO hybrid protein MEN 111300 induces anti-EPO antibodies andsevere anaemia in rhesus monkeys, CYTOKINE, 10(12), 1998, pp. 964-969